Diagnosis of heart failure with preserved ejection fraction: a systematic narrative review of the evidence

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Diagnosis of heart failure with preserved ejection fraction: a systematic narrative review of the evidence ; day:20 ; month:10 ; year:2023 ; pages:1-11
Heart failure reviews ; (20.10.2023), 1-11

Creator: Formiga, Francesc
Nuñez, Julio
Castillo Moraga, María José
Cobo Marcos, Marta
Egocheaga, María Isabel
García-Prieto, Concha F.
Trueba-Sáiz, Angel
Matalí Gilarranz, Arantxa
Fernández Rodriguez, José María

Contributor: SpringerLink (Online service)

DOI: 10.1007/s10741-023-10360-z

URN: urn:nbn:de:101:1-2024013013480806329289

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:26 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Formiga, Francesc
Nuñez, Julio
Castillo Moraga, María José
Cobo Marcos, Marta
Egocheaga, María Isabel
García-Prieto, Concha F.
Trueba-Sáiz, Angel
Matalí Gilarranz, Arantxa
Fernández Rodriguez, José María
SpringerLink (Online service)

Other Objects (12)

$Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction$

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction

$Biomarkers in heart failure with preserved ejection fraction$

Biomarkers in heart failure with preserved ejection fraction

$Comorbidities in heart failure with preserved ejection fraction$

Comorbidities in heart failure with preserved ejection fraction

$Animal models of heart failure with preserved ejection fraction$

Animal models of heart failure with preserved ejection fraction

Heart Failure with Preserved Ejection Fraction—a Concise Review

$Gender-related differences in heart failure with preserved ejection fraction$

Gender-related differences in heart failure with preserved ejection fraction

Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure

$Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment$

Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment

Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction

$Evaluation of mouse models of heart failure with preserved ejection fraction$

Evaluation of mouse models of heart failure with preserved ejection fraction

$Genetic architecture of heart failure with preserved versus reduced ejection fraction$

Genetic architecture of heart failure with preserved versus reduced ejection fraction

$Understanding heart failure with preserved ejection fraction: where are we today?$

Understanding heart failure with preserved ejection fraction: where are we today?

$Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction$

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction

$Biomarkers in heart failure with preserved ejection fraction$

Biomarkers in heart failure with preserved ejection fraction

$Comorbidities in heart failure with preserved ejection fraction$

Comorbidities in heart failure with preserved ejection fraction

$Animal models of heart failure with preserved ejection fraction$

Animal models of heart failure with preserved ejection fraction

Heart Failure with Preserved Ejection Fraction—a Concise Review

$Gender-related differences in heart failure with preserved ejection fraction$

Gender-related differences in heart failure with preserved ejection fraction

Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure

$Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment$

Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment

Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction

$Evaluation of mouse models of heart failure with preserved ejection fraction$

Evaluation of mouse models of heart failure with preserved ejection fraction

$Genetic architecture of heart failure with preserved versus reduced ejection fraction$

Genetic architecture of heart failure with preserved versus reduced ejection fraction

$Understanding heart failure with preserved ejection fraction: where are we today?$

Understanding heart failure with preserved ejection fraction: where are we today?

$Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction$

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction

$Biomarkers in heart failure with preserved ejection fraction$

Biomarkers in heart failure with preserved ejection fraction

$Comorbidities in heart failure with preserved ejection fraction$

Comorbidities in heart failure with preserved ejection fraction

$Animal models of heart failure with preserved ejection fraction$

Animal models of heart failure with preserved ejection fraction

Heart Failure with Preserved Ejection Fraction—a Concise Review

$Gender-related differences in heart failure with preserved ejection fraction$

Gender-related differences in heart failure with preserved ejection fraction

Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure

$Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment$

Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment

Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction

$Evaluation of mouse models of heart failure with preserved ejection fraction$

Evaluation of mouse models of heart failure with preserved ejection fraction

$Genetic architecture of heart failure with preserved versus reduced ejection fraction$

Genetic architecture of heart failure with preserved versus reduced ejection fraction

$Understanding heart failure with preserved ejection fraction: where are we today?$

Understanding heart failure with preserved ejection fraction: where are we today?

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Diagnosis of heart failure with preserved ejection fraction: a systematic narrative review of the evidence

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction

Biomarkers in heart failure with preserved ejection fraction

Comorbidities in heart failure with preserved ejection fraction

Animal models of heart failure with preserved ejection fraction

Heart Failure with Preserved Ejection Fraction—a Concise Review

Gender-related differences in heart failure with preserved ejection fraction

Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure

Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment

Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction

Evaluation of mouse models of heart failure with preserved ejection fraction

Genetic architecture of heart failure with preserved versus reduced ejection fraction

Understanding heart failure with preserved ejection fraction: where are we today?

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction

Biomarkers in heart failure with preserved ejection fraction

Comorbidities in heart failure with preserved ejection fraction

Animal models of heart failure with preserved ejection fraction

Heart Failure with Preserved Ejection Fraction—a Concise Review

Gender-related differences in heart failure with preserved ejection fraction

Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure

Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment

Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction

Evaluation of mouse models of heart failure with preserved ejection fraction

Genetic architecture of heart failure with preserved versus reduced ejection fraction

Understanding heart failure with preserved ejection fraction: where are we today?

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction

Biomarkers in heart failure with preserved ejection fraction

Comorbidities in heart failure with preserved ejection fraction

Animal models of heart failure with preserved ejection fraction

Heart Failure with Preserved Ejection Fraction—a Concise Review

Gender-related differences in heart failure with preserved ejection fraction

Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure

Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment

Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction

Evaluation of mouse models of heart failure with preserved ejection fraction

Genetic architecture of heart failure with preserved versus reduced ejection fraction

Understanding heart failure with preserved ejection fraction: where are we today?

Related objects

Reset password